Wereport a case of Crow-Fukase (POEMS) syndrome associated with pulmonary hypertension (PH). In this case, the concentration of vascular endothelial growth factor (VEGF) was extremely high in the serum, and the levels of IL-1(3, IL-6, TNF-a, and thiamine, which were thought in past reports to be mediators of PHin Crow-Fukasesyndrome, were normal. After prednisolone therapy, PH disappeared with a dramatic decrease in serum VEGF. Our results suggest that VEGFis closely correlated with PH in Crow-Fukase syndrome.
Introduction
Crow-Fukase (POEMS) syndrome is a rare multisystem disorder usually associated with plasma-cell dyscrasia and characterized by five main features, polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (1) . Serum vascular endothelial growth factor (VEGF) levels are specifically elevated in Crow-Fukase syndrome. VEGFis a potent, multifunctional cytokine that induces angiogenesis and microvascular hyperpermeability. A close correlation between the symptoms of Crow-Fukase syndrome and VEGFhas been suggested (2) (3) (4) (5) .
Here, wereport a case of Crow-Fukasesyndromeassociated with pulmonary hypertension (PH) and a high concentration of serum VEGF.
Case Report
In June 1997, a 49-year-old womansuffered from sudden onset of stiff shoulder and occipital pain. Numbnessand edema appeared at distal limbs, which disappeared 10 days later. In February 1998, she felt severe dizziness for one week, followed by fatigability and shoulder discomfort. In March 1998, various symptoms appearedat the sametime. Thesesymptoms were palpitation, exertional dyspnea, numbness and pitting edema at distal limbs, brownish pigmentation of the skin, dysbasia by weakness in the lower extremities, weakness of the fingers, abdominal distention, and hyperhidrosis. A 3 kg weight gain was noted within one month. In May1998, bone X-ray revealed sclerotic lesions in the pelvic bones. Based on the symptoms and sclerotic bone lesions, Crow-Fukase syndrome was clinically entertained. In June 1998, she was admitted to our hospital due to increasing palpitation and exertional dyspnea ( NYHA11°). Her clinical status on admission was as follows: height, 159 cm; body weight, 53 kg; blood pressure, 140/80 mmHg; pulse, regular at 84 beats/min; respiration rate, regular at 20/min. Physical examination revealed two enlarged nontender cervical lymph nodes which were movable and firm. The second heart sound was accentuated. The breath sounds were normal. The liver was palpable 4 cm below the right costal margin and the spleen margin was felt beneath the left costal margin. The abdomen was distended due to ascites. Six angiomas (microscopic diagnosis was capillary hemangioma) were found on the truncal skin. Pitting edemaand hypertrichosis were observed in the distal extremities. Neurological examination revealed papilledema and weakness with atrophy of the muscles in the lower extremities. Glove and stocking type dysesthesia and hypoesthesia were noted, especially in the distal portion of the lower limbs. Deep sensations, including vibratory sense were impaired. Patellar and achilles tendon reflexes were absent. Extrapyramidal and cerebellar system examinations were intact.
The laboratory data obtained upon admission are shown in Table 1 . Mild thrombocytosis was noted. Slightly decreased serum levels of lactate dehydrogenase (LDH) and cholinesterase (Ch-E) were found. Serum y-globulin level was elevated, Papilledemaand visual acuity likewise improved(from 0.9 to 1.5 on the right and from 1.0 to 1.5 on the left) eleven days after the pulse therapy. Thirteen days after therapy, CTscan revealed a reduction of pericardial effusion, pleural effusion, and ascites (Fig. 2) , together with the improvement of cardiomegaly (CTR; 60%to 51.6%) on chest X-ray ( Fig. 1) . Pulmo-Pulmonary Hypertension and VEGF Figure 1 . Changes of chest X-ray findings before (left) and after (right) pulse therapy with methylprednisolone. Improvement of pulmonary congestion and cardiomegaly were noted after the treatment. nary artery systolic blood pressure returned to the normal value by Dopplar echocardiogram on the 1 5th day after pulse therapy (Table 2) ( Fig. 3) . Following pulse therapy, prednisolone at a dose of 50 mg/day was initiated and was tapered gradually. Onemonth after the pulse therapy with methylprednisolone, the patient was administered an anti-thrombin drug (argatroban® 20 mg/day) for eight weeks. Thereafter, there was improvement of polyneuropathy enabling her to ambulate. In October 1998, she was discharged from the hospital taking oral prednisolone at a dose of 20 mg/day.
Discussion
Although we did not directly measure the right ventricular pressure using the Swan-Ganzmethod, a report based on a simultaneous Doppler-catheterization study in 1 27 patients, found the correlation coefficient between Doppler-estimated and catheter-measured right ventricular systolic pressure to be 0.96. Therefore, continuous wave Doppler echocardiography is dependable to accurately estimate PH (6) . PH in Crow-Fukase syndrome has been alluded to in single case reports (7, 8) , and the frequent association of PH has recently been recognized (9, 10) . Lesprit (10) et al reported that 5 out of 20 cases of Crow-Fukasesyndrome were accompanied with PH, and proposed PH as one of the main symptoms of Crow-Fukase syndrome. In these cases of PHwith Crow-Fukase syndrome, no other explanation for PHwas found except for thiamine deficiency (8) , increasing serum proinflammatory cytokines as interleukin-lp (IL-ip ), IL-6, tumor necrosis factor-a (TNF-a), and VEGF (10) . However, the serum VEGFlevel after therapy has never been reported before.
In the present case with PH, serum levels of IL-lp, IL-6, TNFoc , thiamine were normal, however, serum VEGFlevel was markedly increased in association with the characteristic symptoms of Crow-Fukase syndrome. A marked decrease in serum VEGFlevel was observed with improving edema and PH after the pulse therapy of methylprednisolone. Our results suggest that IL-1(3, IL-6, TNF-a, and thiamine may not be direct mediators of PH, and that VEGFis closely correlated with PH in Crow-Fukase syndrome.
VEGFis a multifunctional cytokine that contributes to both vascular hyperpermeability and angiogenesis. Considering that the expression of VEGFis up-regulated by hypoxia (ll) and that PHwas improved soon after the pulse therapy in our case, we speculate the following vicious circle. As a result of increased vascular permeability due to an increased serum VEGF level, pulmonary angioresistance could be raised and gas diffusion capacity may decline from interstitial/perivascular edema. The increased angioresistance could induce PH, while a hypoxia caused by declined gas diffusion capacity may further up-regulate the expression of VEGFin the endothelium ( 1 2). The consequent increase of serum VEGFmay further lead to the progression of angioresistance, that is, pulmonary hypertension. Corticosteroid is effective against PH in Crow-Fukase syndrome, because it is suspected to down-regulate the expression of VEGF,and stabilize the vascular permeability (12, 13) . The mechanism of PH in Crow-Fukase syndrome is still unknown, and further studies will be needed. Crow-Fukase syndrome is an intractable disease, and PH will be an important life-threatening factor in conjunction with heart failure and respiratory insufficiency. The careful watch for PH with the measurement of serum VEGFlevel as an indicator of PH is necessary for the management of Crow-Fukase syndrome.
